Filing Details
- Accession Number:
- 0001209191-20-031845
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 17:37:19
- Reporting Period:
- 2020-05-21
- Accepted Time:
- 2020-05-22 17:37:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326110 | Nantkwest Inc. | NK | Biological Products, (No Disgnostic Substances) (2836) | 431979754 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1647994 | J. Barry Simon | C/O Nantkwest, Inc. 3530 John Hopkins Court San Diego CA 92121 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-21 | 36,932 | $5.52 | 3,269,906 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019.
- Represents the weighted average share price of an aggregate total of 36,932 shares sold in the price range of $5.50 to $5.555 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.